Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data Wesolowska APharmacol Rep 2010[Jul]; 62 (4): 564-77Mental disorders, such as depression and anxiety, pose both medical and social challenges. The clinical efficacy of current antidepressant/anxiolytic therapies is unsatisfactory; both antidepressant and anxiolytic drugs induce a variety of unwanted effects and have delayed onsets of action. Thus, a search for better and safer agents is continuously in progress. Preclinical results published so far have brought new insights into the possible role of recently discovered serotonin 5-HT(6) receptors in these disorders. This review surveys the current state of knowledge regarding potential antidepressant and anxiolytic activities of selective 5-HT(6) receptor ligands, namely, full agonists and antagonists, in animal models commonly used to predict such activity. Evidence indicates that both 5-HT(6) agonists and antagonists may evoke identical responses in animal models of depression and anxiety; however, the possible mechanisms of these effects seem to be diverse and are not clearly understood. Especially interesting are the augmented effects achieved by combining antidepressants or diazepam with a selective 5-HT(6) receptor antagonist.|Animals[MESH]|Anti-Anxiety Agents/pharmacology[MESH]|Antidepressive Agents/pharmacology[MESH]|Anxiety/*drug therapy/physiopathology[MESH]|Depression/*drug therapy/physiopathology[MESH]|Disease Models, Animal[MESH]|Drug Evaluation, Preclinical[MESH]|Humans[MESH]|Receptors, Serotonin/*drug effects/metabolism[MESH]|Serotonin Antagonists/pharmacology[MESH]|Serotonin Receptor Agonists/pharmacology[MESH] |
